AQST logo

Aquestive Therapeutics (AQST) Cash From Operations

Annual CFO

-$35.76 M
-$29.38 M-460.49%

December 31, 2024


Summary


Performance

AQST Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAQSTcash flowmetrics:

Quarterly CFO

-$6.49 M
+$5.39 M+45.38%

December 31, 2024


Summary


Performance

AQST Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAQSTcash flowmetrics:

TTM CFO

-$35.76 M
-$1.55 M-4.52%

December 31, 2024


Summary


Performance

AQST TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAQSTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AQST Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-460.5%0.0%0.0%
3 y3 years-8.4%-176.5%-612.5%
5 y5 years+40.6%-176.5%-612.5%

AQST Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-460.5%at low-173.6%+55.2%-365.3%+6.3%
5 y5-year-460.5%+40.6%-173.6%+55.2%-365.3%+40.6%
alltimeall time-714.0%+40.6%-141.5%+63.3%-365.3%+40.6%

Aquestive Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$35.76 M(+460.5%)
-$6.49 M(-45.4%)
-$35.76 M(+4.5%)
Sep 2024
-
-$11.88 M(+69.6%)
-$34.21 M(+38.6%)
Jun 2024
-
-$7.01 M(-32.5%)
-$24.68 M(-3.5%)
Mar 2024
-
-$10.38 M(+110.1%)
-$25.58 M(+300.9%)
Dec 2023
-$6.38 M(-35.0%)
-$4.94 M(+110.6%)
-$6.38 M(-191.4%)
Sep 2023
-
-$2.35 M(-70.3%)
$6.98 M(-42.5%)
Jun 2023
-
-$7.91 M(-189.7%)
$12.13 M(-10.0%)
Mar 2023
-
$8.82 M(+4.8%)
$13.48 M(-237.3%)
Dec 2022
-$9.82 M(-70.2%)
$8.42 M(+199.6%)
-$9.82 M(-62.7%)
Sep 2022
-
$2.81 M(-142.8%)
-$26.30 M(-31.1%)
Jun 2022
-
-$6.56 M(-54.7%)
-$38.17 M(+14.4%)
Mar 2022
-
-$14.48 M(+79.7%)
-$33.36 M(+1.2%)
Dec 2021
-$32.98 M(-27.5%)
-$8.06 M(-11.1%)
-$32.98 M(-14.2%)
Sep 2021
-
-$9.06 M(+416.2%)
-$38.43 M(+2.0%)
Jun 2021
-
-$1.76 M(-87.5%)
-$37.68 M(-17.9%)
Mar 2021
-
-$14.10 M(+4.3%)
-$45.92 M(+1.0%)
DateAnnualQuarterlyTTM
Dec 2020
-$45.46 M(-24.5%)
-$13.51 M(+62.5%)
-$45.46 M(+6.9%)
Sep 2020
-
-$8.31 M(-16.8%)
-$42.52 M(-13.2%)
Jun 2020
-
-$10.00 M(-26.7%)
-$49.00 M(-12.8%)
Mar 2020
-
-$13.64 M(+29.0%)
-$56.17 M(-6.7%)
Dec 2019
-$60.21 M(+363.5%)
-$10.57 M(-28.5%)
-$60.21 M(+14.8%)
Sep 2019
-
-$14.79 M(-13.8%)
-$52.45 M(+6.7%)
Jun 2019
-
-$17.17 M(-2.9%)
-$49.13 M(+56.2%)
Mar 2019
-
-$17.68 M(+528.7%)
-$31.46 M(+142.1%)
Dec 2018
-$12.99 M(-323.1%)
-$2.81 M(-75.5%)
-$12.99 M(-26.1%)
Sep 2018
-
-$11.47 M(-2345.6%)
-$17.59 M(-284.9%)
Jun 2018
-
$511.00 K(-34.9%)
$9.51 M(+252.2%)
Mar 2018
-
$785.00 K(-110.6%)
$2.70 M(-53.6%)
Dec 2017
$5.82 M(-171.2%)
-$7.41 M(-147.4%)
$5.82 M(-56.0%)
Sep 2017
-
$15.63 M(-348.0%)
$13.23 M(-652.8%)
Jun 2017
-
-$6.30 M(-261.3%)
-$2.39 M(-161.3%)
Mar 2017
-
$3.91 M
$3.91 M
Dec 2016
-$8.18 M
-
-

FAQ

  • What is Aquestive Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Aquestive Therapeutics?
  • What is Aquestive Therapeutics annual CFO year-on-year change?
  • What is Aquestive Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Aquestive Therapeutics?
  • What is Aquestive Therapeutics quarterly CFO year-on-year change?
  • What is Aquestive Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Aquestive Therapeutics?
  • What is Aquestive Therapeutics TTM CFO year-on-year change?

What is Aquestive Therapeutics annual cash flow from operations?

The current annual CFO of AQST is -$35.76 M

What is the all time high annual CFO for Aquestive Therapeutics?

Aquestive Therapeutics all-time high annual cash flow from operations is $5.82 M

What is Aquestive Therapeutics annual CFO year-on-year change?

Over the past year, AQST annual cash flow from operations has changed by -$29.38 M (-460.49%)

What is Aquestive Therapeutics quarterly cash flow from operations?

The current quarterly CFO of AQST is -$6.49 M

What is the all time high quarterly CFO for Aquestive Therapeutics?

Aquestive Therapeutics all-time high quarterly cash flow from operations is $15.63 M

What is Aquestive Therapeutics quarterly CFO year-on-year change?

Over the past year, AQST quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Aquestive Therapeutics TTM cash flow from operations?

The current TTM CFO of AQST is -$35.76 M

What is the all time high TTM CFO for Aquestive Therapeutics?

Aquestive Therapeutics all-time high TTM cash flow from operations is $13.48 M

What is Aquestive Therapeutics TTM CFO year-on-year change?

Over the past year, AQST TTM cash flow from operations has changed by $0.00 (0.00%)